Futility, autonomy, and cost in end-of-life care

Area of Science:

• Bioethics
• Health Economics
• Medical Ethics

Background:

• The denial of medical care based on futility grounds highlights complex ethical dilemmas.
• Decisions regarding treatment near the end of life are increasingly influenced by cost considerations.
• The distinction between refusing and demanding medical treatment is often overlooked in ethical discussions.

Purpose of the Study:

• To examine the ethical implications of incorporating cost into end-of-life treatment decisions.
• To analyze the moral legitimacy of cost-control measures in healthcare.
• To advocate for greater public understanding of the role of cost in healthcare access and affordability.

Main Methods:

• Literature review and ethical analysis of healthcare policy.
• Examination of case studies involving treatment futility and cost.
• Discussion of healthcare reform proposals and ethical frameworks.

Main Results:

• The paper argues that cost is an unavoidable factor in sustainable healthcare systems.
• It highlights the ethical tension between patient demand for treatment and resource limitations.
• Achieving universal access to quality, affordable care requires public acceptance of cost considerations.

Conclusions:

• A nuanced understanding of the moral legitimacy of cost in healthcare decisions is essential.
• Ethical frameworks must evolve to incorporate economic realities, particularly in end-of-life care.
• Public discourse and education are vital for navigating the complexities of healthcare cost control and access.